{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:48:22Z","timestamp":1794674902515,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T00:00:00Z","timestamp":1486684800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol Suppl"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s11789-017-0084-1","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T14:52:46Z","timestamp":1486738366000},"page":"31-37","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Lipoprotein(a) and its role in inflammation, atherosclerosis and malignancies"],"prefix":"10.1007","volume":"12","author":[{"given":"Evelyn","family":"Ors\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,10]]},"reference":[{"key":"84_CR1","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1194\/jlr.M040733","volume":"54","author":"G Leibundgut","year":"2013","unstructured":"Leibundgut G, Scipione C, Yin H, Schneider M, Boffa MB, Green S, Yang X, Dennis E, Witztum JL, Koschinsky ML, Tsimikas S (2013) Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a). J\u00a0Lipid Res 54:2815\u20132830. doi: 10.1194\/jlr.M040733","journal-title":"J Lipid Res"},{"key":"84_CR2","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1194\/jlr.R071233","volume":"57","author":"BG Nordestgaard","year":"2016","unstructured":"Nordestgaard BG, Langsted A (2016) Lipoprotein (a) as a\u00a0cause of cardiovascular disease: insigths from epidemiology, genetics, and biology. J\u00a0Lipid Res 57:1953\u20131975. doi: 10.1194\/jlr.R071233","journal-title":"J Lipid Res"},{"key":"84_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S1567-5688(09)71816-1","volume":"10","author":"E Ors\u00f3","year":"2009","unstructured":"Ors\u00f3 E, Ahrens N, Kilali\u0107 D, Schmitz G (2009) Familial hypercholesterolemia and lipoprotein(a) hyperlipidemia as independent and combined cardiovascular risk factors. Atheroscler Suppl 10:74\u201378. doi: 10.1016\/S1567-5688(09)71816-1","journal-title":"Atheroscler Suppl"},{"key":"84_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11789-015-0074-0","volume":"10","author":"G Schmitz","year":"2015","unstructured":"Schmitz G, Ors\u00f3 E (2015) Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects. Clin Res Cardiol Suppl 10:21\u201325. doi: 10.1007\/s11789-015-0074-0","journal-title":"Clin Res Cardiol Suppl"},{"key":"84_CR5","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1194\/jlr.R061648","volume":"57","author":"SM Marcovina","year":"2016","unstructured":"Marcovina SM, Albers JJ (2016) Lipoprotein (a) measurements for clinical application. J\u00a0Lipid Res 57:526\u2013537. doi: 10.1194\/jlr.R061648","journal-title":"J Lipid Res"},{"key":"84_CR6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/qjmed\/93.2.75","volume":"93","author":"G Lippi","year":"2000","unstructured":"Lippi G, Guidi G (2000) Lipoprotein(a): from ancestral benefit to modern pathogen? Q\u00a0J Med 93:75\u201384","journal-title":"Q J Med"},{"key":"84_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.atherosclerosis.2008.01.002","volume":"201","author":"J Rubin","year":"2008","unstructured":"Rubin J, Kim HJ, Pearson TA, Holleran S, Berglund L, Ramakrishnan R (2008) The apolipoprotein(a) gene: linkage disequilibria at three loci differs in African Americans and Caucasians. Atherosclerosis 201:138\u2013147. doi: 10.1016\/j.atherosclerosis.2008.01.002","journal-title":"Atherosclerosis"},{"key":"84_CR8","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1136\/jmg.2006.042119","volume":"43","author":"JP Chretien","year":"2006","unstructured":"Chretien JP, Coresh J, Berthier-Schaad Y, Kao WH, Fink NE, Klag MJ, Marcovina SM, Giaculli F, Smith MW (2006) Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European Americans. J\u00a0Med Genet 43:917\u2013923. doi: 10.1136\/jmg.2006.042119","journal-title":"J Med Genet"},{"key":"84_CR9","first-page":"463","volume":"56","author":"G Lippi","year":"2010","unstructured":"Lippi G, Targher G, Salvagno GL, Montagnana M, Franchini M, Guidi GC (2010) Lipoprotein(a) and ageing. Clin Lab 56:463\u2013466","journal-title":"Clin. Lab."},{"key":"84_CR10","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0022-2275(20)34933-6","volume":"38","author":"AM Scanu","year":"1997","unstructured":"Scanu AM, Edelstein C (1997) Learning about the structure and biology of human lipoprotein [a] through dissection by enzymes of the elastase family: facts and speculations. J\u00a0Lipid Res 38:2193\u20132206","journal-title":"J Lipid Res"},{"key":"84_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/MOL.0000000000000096","volume":"25","author":"PN Durrington","year":"2014","unstructured":"Durrington PN, Schofield JD, Siahmansur T, Soran H (2014) Lipoprotein (a): gene genie. Curr Opin Lipidol 25:289\u2013296. doi: 10.1097\/MOL.0000000000000096","journal-title":"Curr Opin Lipidol"},{"key":"84_CR12","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jacl.2014.08.003","volume":"8","author":"JP McConnell","year":"2014","unstructured":"McConnell JP, Guadagno PA, Dayspring TD, Hoefner DM, Thiselton DL, Warnich GL, Harris WS (2014) Lipoprotein(a) mass: a massively misunderstood metric. J\u00a0Clin Lipidol 8:550\u2013553. doi: 10.1016\/j.jacl.2014.08.003","journal-title":"J Clin Lipidol"},{"key":"84_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cca.2014.10.013","volume":"439","author":"PA Guadagno","year":"2015","unstructured":"Guadagno PA, Summers Bellin EG, Harris WS, Dayspring TD, Hoefner DM, Thiselton DL, Stanovick B, Warnick GR, McConnell JP (2015) Validation of a\u00a0lipoprotein(a) particle concentration assay by quantitative lipoprotein immunofixation electrophoresis. Clin Chim Acta 439:219\u2013224. doi: 10.1016\/j.cca.2014.10.013","journal-title":"Clin Chim Acta"},{"key":"84_CR14","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/rcm.6883","volume":"28","author":"ME Lassman","year":"2014","unstructured":"Lassman ME, McLaughlin TM, Zhou H, Pan Y, Marcovina SM, Laterza O, Roddy TP (2014) Simultaneous quantitation and size characterization of apolipoprotein(a) by ultra-performance liquid chromatography\/mass spectrometry. Rapid Commun Mass Spectrom 28:1101\u20131106. doi: 10.1002\/rcm.6883","journal-title":"Rapid Commun Mass Spectrom"},{"key":"84_CR15","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1161\/ATVBAHA.116.308011","volume":"36","author":"S Varvel","year":"2016","unstructured":"Varvel S, McConnell JP, Tsimikas S (2016) Prevalence of elevated Lp(a) mass levels and patient thresholds in 532 359 patients in the Unites States. Arterioscler Thromb Vasc Biol 36:2239\u20132245. doi: 10.1161\/ATVBAHA.116.308011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"84_CR16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s00059-006-2714-0","volume":"31","author":"R Leischik","year":"2006","unstructured":"Leischik R, Dworrak B (2006) Lipoprotein(a): Bedeutung f\u00fcr das fibrinolytische System und thromboembolische Komplikationen. Herz 31:144\u2013152. doi: 10.1007\/s00059-006-2714-0","journal-title":"Herz"},{"key":"84_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1042\/BJ20080744","volume":"418","author":"L Liu","year":"2009","unstructured":"Liu L, Craig AW, Meldrum HD, Marcovina SM, Elliott BE, Koschinsky ML (2009) Apolipoprotein(a) stimulates vascular endothelial cell growth and migration and signals through integrin \u03b1V\u03b23. Biochem\u00a0J 418:325\u2013336. doi: 10.1042\/BJ20080744","journal-title":"Biochem J"},{"key":"84_CR18","doi-asserted-by":"publisher","first-page":"30503","DOI":"10.1074\/jbc.M802648200","volume":"283","author":"T Cho","year":"2008","unstructured":"Cho T, Jung Y, Koschinsky ML (2008) Apolipoprotein(a), through its strong lysine-binding site in KIV10, mediates increased endothelial cell contraction and permeability via a\u00a0Rho\/Rho kinase\/MYPT1-dependent pathway. J\u00a0Biol Chem 283:30503\u201330512. doi: 10.1074\/jbc.M802648200","journal-title":"J Biol Chem"},{"key":"84_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1091\/mbc.E12-08-0637","volume":"24","author":"T Cho","year":"2013","unstructured":"Cho T, Romagnuolo R, Scipione C, Boffa MB, Koschinsky ML (2013) Apolipoprotein(a) stimulates nuclear translocation of \u03b2\u2011catenin: a\u00a0novel pathogenis mechanism for lipoprotein(a). Mol Biol Cell 24:210\u2013221. doi: 10.1091\/mbc.E12-08-0637","journal-title":"Mol Biol Cell"},{"key":"84_CR20","doi-asserted-by":"publisher","first-page":"e52287","DOI":"10.1371\/journal.pone.0052287","volume":"8","author":"L Liu","year":"2013","unstructured":"Liu L, Boffa MB, Koschinsky ML (2013) Apolipoprotein(a) inhibits in votro tube formation in endothelial cells: identification of roles for kringle V and the plasminogen activation system. PLOS ONE 8:e52287. doi: 10.1371\/journal.pone.0052287","journal-title":"PLOS ONE"},{"key":"84_CR21","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1016\/j.biocel.2013.05.021","volume":"45","author":"K Riches","year":"2013","unstructured":"Riches K, Franklin L, Maqbool A, Peckham M, Adams M, Bond J, Warburton P, Feric NT, Koschinsky ML, O\u2019Regan DJ, Ball SG, Turner NA, Porter KE (2013) Apolipoprotein(a) acts as a\u00a0chemorepellent to human vascular smooth muscle cells via integrin \u03b1V\u03b23 and RhoA\/ROCK-mediated mechanisms. Int J Biochem Cell Biol 45:1776\u20131783. doi: 10.1016\/j.biocel.2013.05.021","journal-title":"Int J Biochem Cell Biol"},{"key":"84_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/path.4133","volume":"229","author":"A Mantovani","year":"2013","unstructured":"Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M (2013) Macrophage plasticity and polarization in tissue repair and remodeling. J\u00a0Pathol 229:176\u2013185. doi: 10.1002\/path.4133","journal-title":"J Pathol"},{"key":"84_CR23","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood.V97.4.981","volume":"97","author":"C Buechler","year":"2001","unstructured":"Buechler C, Ullrich H, Ritter M, Porsch-Oezcueruemez M, Lackner KJ, Barlage S, Friedrich SO, Kostner GM, Schmitz G (2001) Lipoprotein(a) up-regulates the expression of the plasminogen activator inhibitor-2 in human monocytes. Blood 97:981\u2013986","journal-title":"Blood"},{"key":"84_CR24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0167-4889(03)00083-1","volume":"1642","author":"C Buechler","year":"2003","unstructured":"Buechler C, Ullrich H, Aslanidis C, Bared SM, Lingenhel A, Ritter M, Schmitz G (2003) Lipoprotein(a) down-regulates lisosomal acid lipase and induces interleukin-6 in human blood monocytes. Biochim Biophys Acta 1642:25\u201331","journal-title":"Biochim Biophys Acta"},{"key":"84_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ijc.27706","volume":"132","author":"G Pickert","year":"2013","unstructured":"Pickert G, Lim HY, Weigert A, H\u00e4ussler A, Myrczek T, Waldner M, Labocha S, Ferreir\u00f3s N, Geisslinger G, L\u00f6tsch J, Becker C, Br\u00fcne B, Tegeder I (2013) Inhibition of GTP cyclohydrolase attenuates tumor growth by reducing angiogenesis and M2-like polarization of tumor associated macrophages. Int J Cancer 132:591\u2013604. doi: 10.1002\/ijc.27706","journal-title":"Int J Cancer"},{"key":"84_CR26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.coph.2013.02.005","volume":"13","author":"G Leibundgut","year":"2013","unstructured":"Leibundgut G, Witztum JL, Tsimikas S (2013) Oxidation-specific epitopes and immunological responses: translational biotheranostic implications for atherogenesis. Curr Opin Pharmacol 13:166\u2013179. doi: 10.1016\/j.coph.2013.02.005","journal-title":"Curr Opin Pharmacol"},{"key":"84_CR27","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.jacc.2015.07.020","volume":"66","author":"R Capoulade","year":"2015","unstructured":"Capoulade R, Chan KL, Yeang C, Mathieu P, Boss\u00e9 Y, Dumesnil JG, Tam JW, Teo KK, Mahmut A, Yang X, Witztum JL, Arsenault BJ, Despr\u00e9s JP, Pibarot P, Tsimikas S (2015) Oxidized phospholipids, lipoprotein(a), and progression of calcific aortic valve stenosis. J\u00a0Am Coll Cardiol 66:1236\u20131246. doi: 10.1016\/j.jacc.2015.07.020","journal-title":"J Am Coll Cardiol"},{"key":"84_CR28","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1194\/jlr.M060210","volume":"56","author":"CA Scipione","year":"2015","unstructured":"Scipione CA, Sayegh SE, Romagnuolo R, Tsimikas S, Marcovina SM, Boffa MB, Koschinsky ML (2015) Mechanistic insights into Lp(a)-induce IL-8 expression: a\u00a0role for oxidized phospholipid modification of apo(a). J\u00a0Lipid Res 56:2273\u20132285. doi: 10.1194\/jlr.M060210","journal-title":"J Lipid Res"},{"key":"84_CR29","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1161\/CIRCULATIONAHA.116.020838","volume":"134","author":"FM Valk van der","year":"2016","unstructured":"van der Valk FM, Bekkering S, Kroon J, Yeang C, Van den Bossche J, van Buul JD, Ravandi A, Nederveen AJ, Verberne HJ, Scipione C, Nieuwdorp M, Joosten LA, Netea MG, Koschinsky ML, Witztum JL, Tsimikas S, Riksen NP, Stroes ES (2016) Oxidized phospholipids on lipoprotein(a) elicit arterial wall inflammation and an inflammatory monocyte response in humans. Circulation 134:611\u2013624. doi: 10.1161\/CIRCULATIONAHA.116.020838","journal-title":"Circulation"},{"key":"84_CR30","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1194\/jlr.M036343","volume":"54","author":"P Wiesner","year":"2013","unstructured":"Wiesner P, Tafelmeier M, Chittka D, Choi SH, Zhang L, Byun YS, Almazan F, Yang X, Iqbal N, Chowdhury P, Maisel A, Witztum JL, Handel TM, Tsimikas S, Miller YI (2013) MCP-1 binds to oxidized LDL and is carried by lipoprotein(a) in human plasma. J\u00a0Lipid Res 54:1877\u20131883. doi: 10.1194\/jlr.M036343","journal-title":"J Lipid Res"},{"key":"84_CR31","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1161\/circresaha.113.301145","volume":"114","author":"D Tsiantoulas","year":"2014","unstructured":"Tsiantoulas D, Diehl CJ, Witztum JL, Binder CJ (2014) B cells and humoral immunity in atherosclerosis. Circ Res 114:1743\u20131756. doi: 10.1161\/circresaha.113.301145","journal-title":"Circ Res"},{"key":"84_CR32","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1172\/jci36800","volume":"119","author":"MY Chou","year":"2009","unstructured":"Chou MY, Fogelstrand L, Hartvigsen K, Hansen LF, Woelkers D, Shaw PX, Choi J, Perkmann T, B\u00e4ckhed F, Miller YI, H\u00f6rkk\u00f6 S, Corr M, Witztum JL, Binder CJ (2009) Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J\u00a0Clin Invest 119:1335\u20131349. doi: 10.1172\/jci36800","journal-title":"J Clin Invest"},{"issue":"1","key":"84_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1161\/circresaha.116.309606","volume":"120","author":"D Tsiantoulas","year":"2016","unstructured":"Tsiantoulas D, Bot I, Ozsvar Kozma M, Goederle L, Perkmann T, Hartvigsen K, Conrad DH, Kuiper J, Mallat Z, Binder CJ (2016) Increased plasma IgE accelerate atherosclerosis in secreted IgM deficiency. Circ Res 120(1):78\u201384. doi: 10.1161\/circresaha.116.309606","journal-title":"Circ Res"},{"key":"84_CR34","doi-asserted-by":"crossref","first-page":"9163","DOI":"10.1074\/jbc.275.13.9163","volume":"275","author":"A Boullier","year":"2000","unstructured":"Boullier A, Gillotte KL, H\u00f6rkk\u00f6 S, Green SR, Friedman P, Dennis EA, Witztum JL, Steinberg D, Quehenberger O (2000) The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J\u00a0Biol Chem 275:9163\u20139169","journal-title":"J Biol Chem"},{"key":"84_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2008.02.043","volume":"133","author":"Y Imai","year":"2008","unstructured":"Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen R, Leung YH, Wang H, Liu H, Sun Y, Pasparakis M, Kopf M, Mech C, Bavari S, Peiris JS, Slutsky AS, Akira S, Hultqvist M, Holmdahl R, Nicholls J, Jiang C, Binder CJ, Penninger JM (2008) Identification of oxidative stress and Toll-like receptor 4 signaling as a\u00a0key pathway of acute lung injury. Cell 133:235\u2013249. doi: 10.1016\/j.cell.2008.02.043","journal-title":"Cell"},{"key":"84_CR36","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1194\/jlr.m600361-jlr200","volume":"48","author":"S Tsimikas","year":"2007","unstructured":"Tsimikas S, Brilakis ES, Lennon RJ, Miller ER, Witztum JL, McConnell JP, Kornman KS, Berger PB (2007) Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events. J\u00a0Lipid Res 48:425\u2013433. doi: 10.1194\/jlr.m600361-jlr200","journal-title":"J Lipid Res"},{"key":"84_CR37","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1194\/jlr.m015776","volume":"52","author":"A Ravandi","year":"2011","unstructured":"Ravandi A, Boekholdt SM, Mallat Z, Talmud PJ, Kastelein JJ, Wareham NJ, Miller ER, Benessiano J, Tedgui A, Witztum JL, Khaw KT, Tsimikas S (2011) Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk study. J\u00a0Lipid Res 52:1829\u20131836. doi: 10.1194\/jlr.m015776","journal-title":"J Lipid Res"},{"issue":"12","key":"84_CR38","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1002\/1529-0131(199912)42:12<2606::aid-anr14>3.0.co;2-x","volume":"42","author":"FI Romero","year":"1999","unstructured":"Romero FI, Atsumi T, Tinahones FJ, G\u00f3mez-Zumaquero JM, Amengual O, Khamashta MA, Hughes GR (1999) Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome. Arthritis Rheum 42(12):2606\u20132611. doi: 10.1002\/1529-0131(199912)42:12<2606::aid-anr14>3.0.co;2-x","journal-title":"Arthritis Rheum"},{"key":"84_CR39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1191\/096120300678828253","volume":"9","author":"FI Romero","year":"2000","unstructured":"Romero FI, Khamashta MA, Hughes GR (2000) Lipoprotein(a) oxidation and autoantibodies: a\u00a0new path in atherothrombosis. Lupus 9:206\u2013209","journal-title":"Lupus"},{"key":"84_CR40","first-page":"273","volume":"79","author":"MS O\u2019Reilly","year":"1997","unstructured":"O\u2019Reilly MS (1997) Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth. EXS 79:273\u2013294","journal-title":"EXS"},{"key":"84_CR41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ctrv.2007.02.006","volume":"33","author":"G Lippi","year":"2007","unstructured":"Lippi G, Franchini M, Salvagno GL, Guidi GC (2007) Lipoprotein[a] and cancer: anti-neoplastic effect besides its cardiovascular potency. Cancer Treat Rev 33:427\u2013436. doi: 10.1016\/j.ctrv.2007.02.006","journal-title":"Cancer Treat Rev"},{"key":"84_CR42","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3892\/ijo.2016.3597","volume":"49","author":"J Cha","year":"2016","unstructured":"Cha J, Roomi MW, Kalinovsky T, Niedzwiecki A, Rath M (2016) Lipoprotein(a) and vitamin C impair development of breast cancer tumors in Lp(a)+; Gulo-\/- mice. Int J Oncol 49:895\u2013902. doi: 10.3892\/ijo.2016.3597","journal-title":"Int J Oncol"},{"key":"84_CR43","doi-asserted-by":"publisher","first-page":"e31954","DOI":"10.1371\/journal.pone.0031954","volume":"7","author":"M Sawabe","year":"2012","unstructured":"Sawabe M, Tanaka N, Mieno MN, Ishikawa S, Kayaba K, Nakahara K, Matsushita S, JMS Cohort Study Group (2012) Low lipoprotein(a) concentration is associated with cancer and all-cause deaths: a\u00a0population-based cohort study (the JMS cohort study). PLOS ONE 7:e31954. doi: 10.1371\/journal.pone.0031954","journal-title":"PLOS ONE"},{"key":"84_CR44","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.canep.2014.07.013","volume":"38","author":"MN Mieno","year":"2014","unstructured":"Mieno MN, Sawabe M, Tanaka N, Nakahara K, Hamamatsu A, Chida K, Sakurai U, Arai T, Harada K, Mori S, Inamatsu T, Ozawa T, Honma N, Aida J, Takubo K, Matsushita S (2014) Significant association between hypolipoproteinemia(a) and lifetime risk of cancer: an autopsy study from a\u00a0community-based Geriatric Hospital. Cancer Epidemiol 38:550\u2013555. doi: 10.1016\/j.canep.2014.07.013","journal-title":"Cancer Epidemiol"},{"key":"84_CR45","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1515\/cclm.2009.094","volume":"47","author":"HH Yang","year":"2009","unstructured":"Yang HH, Chen XF, Hu W, Lv DQ, Ding WJ, Tang LJ, Jiang JJ, Ye MH (2009) Lipoprotein(a) level and its association with tumor stage in male patients with primary lung cancer. Clin Chem Lab Med 47:452\u2013457. doi: 10.1515\/cclm.2009.094","journal-title":"Clin Chem Lab Med"},{"key":"84_CR46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/jop.12344","volume":"45","author":"G Li","year":"2016","unstructured":"Li G, Da M, Zhang W, Wu H, Ye J, Chen J, Ma L, Gu N, Wu Y, Song X (2016) Alteration of serum lipid profile and its prognostic value in head and neck squamous cell carcinoma. J\u00a0Oral Pathol Med 45:167\u2013172. doi: 10.1111\/jop.12344","journal-title":"J Oral Pathol Med"}],"container-title":["Clinical Research in Cardiology Supplements"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11789-017-0084-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11789-017-0084-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11789-017-0084-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T00:01:25Z","timestamp":1658620885000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11789-017-0084-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,10]]},"references-count":46,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["84"],"URL":"https:\/\/doi.org\/10.1007\/s11789-017-0084-1","relation":{},"ISSN":["1861-0706","1861-0714"],"issn-type":[{"value":"1861-0706","type":"print"},{"value":"1861-0714","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,10]]}}}